Primary Tumor-Related Complications and Salvage Outcomes in Patients with Metastatic Rectal Cancer and an Untreated Primary Tumor

被引:6
|
作者
Tan, Winson J. [1 ,2 ]
Patil, Sujata [3 ]
Guillem, Jose G. [1 ]
Paty, Philip B. [1 ]
Weiser, Martin R. [1 ]
Nash, Garrett M. [1 ]
Smith, J. Joshua [1 ]
Pappou, Emmanouil P. [1 ]
Wei, Iris H. [1 ]
Garcia-Aguilar, Julio [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Colorectal Serv, Dept Surg, 1275 York Ave, New York, NY 10065 USA
[2] Sengkang Gen Hosp, Dept Gen Surg, Singapore, Singapore
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Complications; Metastasis; Rectal cancer; Salvage; Untreated primary tumor; IV COLORECTAL-CANCER; RECEIVING CHEMOTHERAPY; RESECTION; SURVIVAL; METAANALYSIS; SURGERY; THERAPY; COLON;
D O I
10.1097/DCR.0000000000001803
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: For rectal cancer with unresectable metastases, current practice favors omitting interventions directed at the primary tumor in asymptomatic patients. OBJECTIVE: This study aimed to determine the proportion of patients with primary tumor-related complications, characterize salvage outcomes, and measure survival in patients with metastatic rectal cancer who did not undergo upfront intervention for their primary tumor. DESIGN: This is a retrospective analysis. SETTING: This study was conducted at a comprehensive cancer center. PATIENTS: Patients who presented between January 1, 2008, and December 31, 2015, with synchronous stage IV rectal cancer, an unresected primary tumor, and no prior primary tumor-directed intervention were selected. MAIN OUTCOME MEASURES: The main outcome measured was the rate of primary tumor-related complications in the cohort that did not receive any primary tumor-directed intervention. The Kaplan-Meier method and Cox regression analysis were used to determine whether complications are associated with survival. RESULTS: The cohort comprised 358 patients with a median age of 56 years (22-92). Median follow-up was 26 months (range, 1-93 months). Among the 168 patients (46.9%) who eventually underwent elective resection of the primary tumor, the surgery was performed with curative intent in 66 patients (18.4%) and preemptive intent in 102 patients (28.5%). Of the 190 patients who did not undergo an upfront or elective intervention for the primary tumor, 68 (35.8%) experienced complications. Nonsurgical intervention for complications was attempted in 34 patients with an overall success rate of 61.8% (21/34). Surgical intervention was performed in 47 patients (including 13 patients for whom nonsurgical intervention failed): diversion in 26 patients and resection in 21 patients. Of those 47 patients, 42 (89.4%) ended up with a colostomy or ileostomy. LIMITATIONS: This study was conducted at a single center. CONCLUSION: A significant proportion of patients with metastatic rectal cancer and untreated primary tumor experience primary tumor-related complications. These patients should be followed closely, and preemptive intervention (resection, diversion, or radiation) should be considered if the primary tumor progresses despite systemic therapy.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [31] Rectal cancer and synchronous metastases: Resection of primary tumor or not?
    Trarbach, T.
    Schmoll, H. J.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (12): : 1098 - 1100
  • [32] Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
    Kumar, Rajiv
    Price, Timothy J.
    Beeke, Carol
    Jain, Kunal
    Patel, Gargi
    Padbury, Rob
    Young, Graeme P.
    Roder, David
    Townsend, Amanda
    Bishnoi, Sarwan
    Karapetis, Christos S.
    CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 87 - 93
  • [33] KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma
    Ekinci, Ahmet Siyar
    Demirci, Umut
    Oksuzoglu, Berna Cakmak
    Ozturk, Ayse
    Esbah, Onur
    Ozatli, Tahsin
    Celik, Burcin
    Budakoglu, Burcin
    Turker, Ibrahim
    Bal, Oznur
    Turan, Nedim
    JOURNAL OF BUON, 2015, 20 (01): : 128 - 135
  • [34] Neutrophil-related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy
    Colloca, Giuseppe Antonio
    Venturino, Antonella
    Guarneri, Domenico
    CLINICAL COLORECTAL CANCER, 2019, 18 (04) : E343 - E348
  • [35] A population-based predictive model predicting candidate for primary tumor surgery in patients with metastatic esophageal cancer
    Liu, Zhichao
    Zhang, Xiaobin
    Li, Bin
    Jiang, Haoyao
    Yang, Yang
    Hua, Rong
    Sun, Yifeng
    Li, Zhigang
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02)
  • [36] Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
    Li, Qingguo
    Wang, Changjian
    Li, Yaqi
    Li, Xinxiang
    Xu, Ye
    Cai, Guoxiang
    Lian, Peng
    Cai, Sanjun
    ONCOTARGET, 2017, 8 (29) : 48333 - 48342
  • [37] Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer
    Kim, Hye Jin
    Kang, Eunyoung
    Kim, Jee Hyun
    Kim, Se Hyun
    Kim, Yu Jung
    Kim, In Ah
    Eom, Keun-Yong
    Chae, Su Min
    Kang, Kyu Min
    Kim, Eun Kyu
    Kim, Sung-Won
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1037 - E1044
  • [38] Efficacy of Primary Tumor Resection in Metastatic Colorectal Cancer
    Huang, Yong
    Ge, Kuanxue
    Fu, Guangshun
    Chu, Junfeng
    Wei, Wei
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [39] Prognostic Significance of Host- and Tumor-Related Factors in Patients with Gastric Cancer
    Mohri, Yasuhiko
    Tanaka, Kouji
    Ohi, Masaki
    Yokoe, Takeshi
    Miki, Chikao
    Kusunoki, Masato
    WORLD JOURNAL OF SURGERY, 2010, 34 (02) : 285 - 290
  • [40] Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
    Cifuentes, Federico F.
    Valenzuela, Rodrigo H.
    Contreras, Hector R.
    Castellon, Enrique A.
    ONCOLOGY REPORTS, 2015, 34 (06) : 2837 - 2844